- Home
- OTLK vs HITI Comparison
OTLK vs HITI Comparison
Compare OTLK & HITI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OTLK | HITI |
|---|---|---|
| Founded | 2010 | 2009 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 249.6M | 220.6M |
| IPO Year | 2016 | 2021 |
Fundamental Metrics
Financial Performance| Metric | OTLK | HITI |
|---|---|---|
| Price | $0.57 | $2.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | ★ $5.03 | $4.67 |
| AVG Volume (30 Days) | ★ 3.4M | 749.3K |
| Earning Date | 08-14-2026 | 09-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 55.91 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,146,123.00 | N/A |
| Revenue This Year | N/A | $27.52 |
| Revenue Next Year | $6,355.64 | $10.52 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.16 | $2.02 |
| 52 Week High | $2.54 | $3.80 |
Technical Indicators
Market Signals| Indicator | OTLK | HITI |
|---|---|---|
| Relative Strength Index (RSI) | 31.66 | 55.89 |
| Support Level | $0.50 | $2.29 |
| Resistance Level | $0.72 | $2.88 |
| Average True Range (ATR) | 0.04 | 0.12 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 0.06 | 63.51 |
Price Performance
Historical ComparisonAbout OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA, which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About HITI High Tide Inc.
High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, and others. The company's reportable operating segments are: Bricks and mortar, which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada, followed by the United States of America, and other international markets.